| 摘要 |
<p>The invention relates generally to the changes in gene expression in Benign Prostatic Hyperplasia (BPH). The invention relates specifically to a human gene family which corresponds to mRNA species that are differentially expressed in BPH compared to normal prostate tissue.</p> |
